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Abstract 
Accountable Care Organizations (ACOs) in the United States of
America (USA) and Clinical Commissioning Groups (CCGs) in the
United Kingdom (UK) are newly proposed cross-organisational struc-
tures in health services both tasked with a role which includes improv-
ing public health. Although there are very significant differences
between the UK and USA health systems, there appears to be some
similar confusion as to how ACOs and CCGs will regard and address
public or population health. This short perspective article gives an
overview of ACOs in the USA and CCGs in the UK, with the underlying
context of possible public health functions. It concludes by considering
the challenges facing both countries and highlighting the opportunity
for shared learning.
Introduction
There are significant differences between the health systems in the
United States of America (USA) and the United Kingdom (UK). The
UK operates a tax-based National Health Service (NHS) which
ensures equal provision for all UK citizens. This is in contrast to the
insurance based system in the USA which results in variable provision
for the population. Although estimates vary, and basic state funded
healthcare is available for children, the poor, and the elderly, tens of
millions of Americans remain uninsured.1 A major focus of US health
policy has been to increase coverage to address this deficit in access,
whereas in the UK improving quality and reducing costs have been
more prominent themes.2
An analysis of the health systems of twelve countries in 2011, using
Organization for Economic Cooperation and Development data from
2010, included both the UK and the USA.3 The USA had the largest
financial investment in healthcare, spending about double the propor-
tion of gross domestic product compared to the UK. Yet, despite high-
er spending, the USA had fewer doctors and consultations than in the
UK. Medication was more frequently prescribed in the USA, and there
were vastly more diagnostic scanning machines per million population
compared to the UK. Comparisons of performance were mixed.
However, despite these vast differences, both countries have some-
thing to learn from each other. This shared learning has been more
successful at a clinical level, yet it has been suggested that there are
several areas in which it could also be possible at an organisational
level. For example, the UK could learn from the US experience of low
cost high performance centres for complicated interventions.4
At the present moment, both the UK and USA are embracing funda-
mental changes to their healthcare systems. Specifically, Accountable
Care Organizations (ACOs) in the USA and Clinical Commissioning
Groups (CCGs) in the UK are newly proposed cross-organisational
structures in health services. Both have a wide range of possible func-
tions and, interestingly, both have been tasked with a role in improv-
ing public health. ACOs are expected to improve the population health
of their patients, and CCGs are expected to reflect public health prior-
ities in their commissioning plans.
Preventive medicine has had a more prominent focus in the USA
since President Obama initiated his plans for USA healthcare in 2008.5
There was the same shift in focus with the change in government in
the UK in 2010; initial plans of the incoming government included
changing the name of the Department of Health to the Department of
Public Health,6 although this has not been done. 
It is as yet unclear how ACOs and CCGs will handle public health,
which aspects they will focus on, and what resources will be at their dis-
posal. However, even though it is very early days, and although provi-
sion in the USA and UK for healthcare and public health are very differ-
ent, there are parallels in the conceptualisation of these new organisa-
tional structures and how they may address improving public health.
This short perspective article gives an overview of ACOs in the USA and
CCGs in the UK, with the underlying context of possible public health
functions, and concludes by considering the challenges facing both
countries and highlighting the opportunity for shared learning.
USA: Accountable Care Organizations andpopulation health
The Patient Protection and Affordable Care Act (ACA) 2010, Section
3022, created the mandate for the development of ACOs.7 It is envi-
sioned that existing healthcare provider organisations with sufficient
primary care capacity, integrated care arrangements and registered
patients will form conglomerates of ACOs. Their main intended func-
tion is to achieve a measurable improvement in quality of healthcare
and a reduction in healthcare costs.8 ACOs are umbrella organisations
that seek to bring together different types of healthcare groups, and
have the potential to improve integrated care pathways, reduce the
Significance for public health
The United States of America’s (USA) government has given Accountable
Care Organizations (ACOs) multiple different functions. One of these is
improving the population health of their registered patients. How ACOs in
the USA understand their role in improving the population health of their
patients has yet to be explained. Likewise in the United Kingdom (UK), as
Clinical Commissioning Groups (CCGs) take on a new role including func-
tions related to public health, many of the roles proposed are not clear. There
are possible lessons that emerging ACOs in the USA and CCGs in the UK
could share to improve public health, and further research is required.
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costs associated with unnecessary duplication, and encourage different
providers to work together to reduce avoidable emergency room atten-
dances and repeated admissions to hospital.9 Other aims include a
commitment to evidence based medicine and individual patient
involvement in their care and at board level. In addition, embracing
innovation, learning to maximise information technology (e.g. elec-
tronic patient records), and promoting clinical management and lead-
ership are postulated to be key steps for ACOs.10
The US has for many years tried to improve integrated care arrange-
ments between primary and secondary care and other levels. ACOs rep-
resent a continuing attempt to streamline health services by bringing
several different providers under a common system.11 Several types of
organisations could potentially become ACOs, including: integrated
delivery systems, multispeciality group practices, independent practice
associations, virtual physician organisations, and physician-hospital
organisations.9,10 The aim of reducing duplication and improving coor-
dination could increase quality of care, and drive down costs.
Minimum prerequisites to obtaining ACO status include a 3-year
contract with a population of at least 5000 patients. Incentives are pri-
marily financial (in terms of shared savings) from the Centers for
Medicare and Medicaid Services (CMS) fee-for-service payment
model.12,13 A part of the savings is retained by the ACOs and passed on
by them to individual provider organisations that make up the ACOs.
Groups of physician led organisations can apply through CMS for ACO
status. Since their inception, ACOs have received considerable cover-
age in medical journals and the lay media.14,15 Online learning groups
to support emerging ACOs are beginning to gather momentum.16,17
Professor Donald Berwick, while Administrator of CMS wrote in 2011
in the New England Journal of Medicine: The creation of ACOs is one of
the first delivery-reform initiatives that will be implemented under the
ACA. Its purpose is to foster change in patient care so as to accelerate
progress toward a three-part aim: better care for individuals, better
health for populations, and slower growth in costs through improve-
ments in care.18 Yet, despite this interest and the high level support
epitomised by Berwick’s comment, the role of ACOs in improving pop-
ulation health and evaluating the health needs of their registered
patients remains ill-defined and poorly explored.
Berwick also outlines the expectation that ACOs will tackle their
patients’ needs for preventing disease and utilise health intelligence
data to address population health.18 Other key commentators have also
reported population health as an agreed priority for ACOs.19 CMS
released 65 performance metrics in five domains for ACOs.20 Nine of
these are specifically in the area of preventive medicine, including:
vaccination, screening, tobacco cessation interventions and adult
weight screening. In other domains, targets for controlling diabetes,
cardiovascular disease and other chronic diseases predominate.
It seems apparent that ACO policy-makers intend ACOs to not only
improve quality of healthcare and save money, but also to take respon-
sibility for the health and well-being of their registered patient popula-
tion.21 In other words, as well as providing reactive care to individuals
who are ill or believe themselves to be ill, ACOs must provide proactive
care to people who are not (currently) patients, even though they are
registered with an insurance plan. Establishing how ACOs perceive the
challenge of improving the population health of their registered
patients, and whether their perceptions are realistic and feasible, has
implications for their long-term success.
UK: Clinical Commissioning Groups and publichealth
The USA and UK differ in their definition of population and public
health. In the UK, population health is thought of as virtually synony-
mous with public health (the terms are often used interchangeably).
There are three principal domains of public health: health protection,
health promotion, and health services’ public health.22
Health protection is led by the Health Protection Agency which is
responsible for all biological, chemical and radiological threats to
human health (the equivalent of the Communicable Disease Control
Center or CDC in the USA). This includes contact tracing and control
of infectious disease, quantitative assessment of toxicity to guide
interventions, and health intelligence support for all healthcare organ-
isations in the UK to handle such incidents. Health promotion concerns
interventions aimed at enabling individuals and communities to cease
unhealthy behaviour patterns and adopt healthier ones. For example,
the availability of tobacco cessation interventions or support for cater-
ing businesses to adopt healthier cooking practices. These functions
are currently divided between the NHS and local government.
The last domain, health services’ public health, is the least under-
stood even within the UK public health system. This is compounded by
a current reorganisation of the NHS,23 of which public health is cur-
rently a core part, accounting for approximately 4% of the NHS budg-
et.24 Public health departments are currently located within Primary
Care Trusts (PCTs) which are the commissioning bodies for local pop-
ulations (and are in some ways similar to ACOs) especially proposed
community models. Public health departments advise healthcare com-
missioners on the quality and performance of healthcare services. In
addition, public health specialists work at regional and national levels
to perform similar functions for specialist services, and to develop
guidelines and health intelligence in bodies such as the National
Institute for Health and Clinical Excellence.25
Health protection (particularly related to hygiene and sanitation)
and high-level health promotion (e.g. national advertising for healthier
eating) would typically be considered as public health in the USA
(although it should be noted there are no hard and fast rules).
Population health in US terms has a more specific meaning and may be
applied to preventive medicine functions of healthcare organisations.
This distinction is less clear in the UK, as described above. 
In the current UK NHS re-organisation, control and commissioning
of appropriate local healthcare services are passing from PCTs to new
cross-organisational structures (currently under development) called
Clinical Commissioning Groups (CCGs). These groups aim to be, like
ACOs, physician led. They will also assume a role for public health,26
but this role, like that of the newly-formed ACOs, is currently unclear.
Plans for the public health role state: clinical commissioning groups...
will receive specialist population health commissioning advice from
directors of public health.27
A new structure called Public Health England is in the process of
being formed to house some of the public health functions described
above. Local government will take much more responsibility for public
health outcomes, hosting health and well-being boards, a conglomerate
of all parties with an interest or duty to improve public health. It is
intended that CCGs will be an integral part of this set-up, with a role in
health and well-being plans, and with the intention that this will also
inform their commissioning activities.28
In the UK, information for public health is ubiquitous and has tradi-
tionally been handled by public health specialists and ancillary staff.
Members of CCGs will need to have skills in handling health informa-
tion in order to commission services.29 Yet there is evidence to suggest
that, at least for general practitioners, both skills in handling and using
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health information for commissioning may be limited.30 This could be
linked to: i) lack of training in handling and processing population level
data; ii) lack of skills in prioritising health information based on health
needs as opposed to exclusively service demands or cost savings; and
iii) lack of experience in using health information selectively to plan
and manage services and public health interventions. Making use of
existing public health specialists and their skills will be critical for
CCGs, although details of exactly how this will be brought about are as
yet unclear.31
Future challenges and learning
There are lessons that ACOs in the USA and CCGs in the UK could
learn from each other as they evolve to improve public health outcomes
in the communities they serve.
ACOs have been tasked with multiple different functions by the US
government. One of these is improving the population health of their
registered patients. How ACOs in the USA understand their role in
improving the population health of their patients is yet to be explained.
The expectations of ACO policy leaders in government, academia, poli-
cy think-tanks and other relevant groups for ACOs to address the popu-
lation health of their registered patients may be quite different to how
individual ACOs currently understand and are planning this new role.
Will they even think it is their role at all? Likewise in the UK, as CCGs
take on a role in public health, many proposed functions are unclear and
members of CCGs may lack the skills needed to address these issues.
ACOs and CCGs have different roles in different contexts but both
are innovative and new. Research into their function needs to go
beyond transatlantic comparisons and draw out lessons for shared
learning. As has been previously noted, the experience of novel health
systems in one country should also be seen as pilots for other coun-
tries.32 This could especially be the case when there are similarities in
proposed functions, as is the apparent case with ACOs and CCGs.
Context is critical. The UK spends less on healthcare than the USA
but has greater access to services. CCGs face spending cuts and deci-
sions regarding prioritisation, but they will probably not have the
option to ignore sections of the population’s health. This allows a real
effort to be made to improve public health. In contrast, ACOs have a
defined insured population which will not necessarily be representative
of the city or town of its location. By definition, improving all local pub-
lic health will be problematic. Interventions, though, are a large part of
US healthcare, and even if ACOs fail to reach entire populations they
may be better placed and funded to provide successful preventive med-
icine than CCGs facing spending cuts. CCGs may be reduced to funding
acute care, with few resources left over to tackle the underlying causes
of poor health.
Putting public health in the hands of healthcare providers or health
service commissioners risks creating practical and philosophical ten-
sions between individual and public health perspectives, e.g. a popula-
tion orientation is underpinned by utilitarian ethics (the greatest good
for the greatest number) whereas an individual orientation is under-
pinned by deontological ethics (the professional obligation to the indi-
vidual patient). How ACOs and CCGs will address this dichotomy has
yet to be seen and this is a likely area of fruitful and interesting quali-
tative health services’ research. CCGs in the UK that adopt a PCT style
approach may be better placed to address public health as they will
inherit a skilled workforce. Those that adopt a private sector model may
have a less certain future for tackling population health issues.
Likewise in the USA, as community based ACOs begin to emerge and
consider taking population health responsibilities, and possible invest-
ment of shared savings in local population health goals,33 improving
public health may become more intrinsic to their overall functioning.
Although there are very significant differences between the UK and
USA health systems, there appears to be a similar confusion as to how
CCGs and ACOs will regard and address public health. Lessons learned
from the USA and UK experience may inform mechanisms for physi-
cian led organisations in the UK and the USA to assess health needs,
use population health information and improve population health out-
comes. This comparison is particularly relevant given the massive
restructuring of health systems in both the USA and UK, a redefining
of commissioning of public health in the UK, and a potential new role
for ACOs addressing population health in the USA. Further research
into these emerging new structures using organisational theory is
required to reveal mechanisms for improving public health that can be
shared between the two countries.
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